Also from this source

You just read:

Lixte Biotechnology Holdings, Inc. Announces That Its Novel Protein Phosphatase 2A Inhibitor Is Associated With Stabilization Of Several Types Of Cancer Without Dose-Limiting Toxicity

News provided by

Lixte Biotechnology Holdings, Inc.

Nov 06, 2015, 12:30 EST